We did not detect correlations with CD8+ and CD4+ T-cell responses with circulating DC metabolism, however we observed an increased expression of the checkpoint receptor ILT3 on selected monocyte and conventional DC subtypes in melanoma patients, which significantly associated with decreased OS. This evidence concerns the gene LILRB4 and melanoma.